INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
PATIENT REVENUES, NET	$ 111,270	$ 118,243	$ 224,630	$ 238,230
OTHER OPERATING INCOME	8,547	5,148	19,868	5,148
EXPENSES:
Operating	91,598	95,775	188,427	190,634
Lease and rent expense	13,264	13,523	26,513	27,036
Professional liability	1,484	2,114	3,567	3,953
General and administrative	6,976	6,880	13,741	13,638
Depreciation and amortization	2,374	2,278	4,669	4,565
Total expenses	115,696	120,570	236,917	239,826
OPERATING INCOME	4,121	2,821	7,581	3,552
OTHER INCOME (EXPENSE):
Other income	174	409	213	524
Interest expense, net	(1,087)	(1,209)	(2,109)	(2,669)
Total other expense	(913)	(800)	(1,896)	(2,145)
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	3,208	2,021	5,685	1,407
PROVISION FOR INCOME TAXES	(354)	(182)	(697)	(78)
INCOME FROM CONTINUING OPERATIONS	2,854	1,839	4,988	1,329
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit	(360)	(387)	(606)	(630)
NET INCOME	$ 2,494	$ 1,452	$ 4,382	$ 699
Per common share – basic
Continuing operations (in dollars per share)	$ 0.43	$ 0.28	$ 0.75	$ 0.21
Discontinued operations (in dollars per share)	(0.05)	(0.06)	(0.09)	(0.10)
Net income per common share – basic (in dollars per share)	0.38	0.22	0.66	0.11
Per common share – diluted
Continuing operations (in dollars per share)	0.42	0.28	0.74	0.21
Discontinued operations (in dollars per share)	(0.05)	(0.06)	(0.09)	(0.10)
Net income per common share – diluted (in dollars per share)	$ 0.37	$ 0.22	$ 0.65	$ 0.11
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	6,643	6,649	6,607	6,506
Diluted (in shares)	6,752	6,704	6,746	6,586
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	dvcr:PatientRevenuesNetMember	dvcr:PatientRevenuesNetMember	dvcr:PatientRevenuesNetMember	dvcr:PatientRevenuesNetMember